← FDA DRUG APPROVALS

FDA ANDA · ANDA079239

GEMFIBROZIL

Sponsor: SUN PHARM INDS INC

APPLICATION
ANDA079239
TYPE
ANDA
ORIGINAL APPROVAL
2008-12-29
LATEST ACTION
2015-06-04
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

GEMFIBROZILDiscontinued
GEMFIBROZIL 600MG · TABLET · ORAL

Approval history

2015-06-04Labeling · Supplement 10 · standardAP
2015-06-04Labeling · Supplement 9 · standardAP
2011-09-27Labeling · Supplement 7AP
2009-12-15Labeling · Supplement 4AP
2008-12-29OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →